Literature DB >> 33139435

Kieran L Quinn1, Michael Fralick2, Jonathan S Zipursky2, Nathan M Stall2.   

Abstract

Entities:  

Year:  2020        PMID： 33139435      PMCID： PMC7647486          DOI： 10.1503/cmaj.200619-f

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

Review 1.  Immortal time bias in pharmaco-epidemiology.

Authors:  Samy Suissa
Journal:  Am J Epidemiol       Date:  2007-12-03       Impact factor: 4.897

2.  COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?

Authors:  Ankit B Patel; Ashish Verma
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

3.  The 2017 Clinical Practice Guideline for High Blood Pressure.

Authors:  Paul K Whelton; Robert M Carey
Journal:  JAMA       Date:  2017-12-05       Impact factor: 56.272

4.  Preventing a covid-19 pandemic.

Authors:  John Watkins
Journal:  BMJ       Date:  2020-02-28

5.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.

Authors:  Chaomin Wu; Xiaoyan Chen; Yanping Cai; Jia'an Xia; Xing Zhou; Sha Xu; Hanping Huang; Li Zhang; Xia Zhou; Chunling Du; Yuye Zhang; Juan Song; Sijiao Wang; Yencheng Chao; Zeyong Yang; Jie Xu; Xin Zhou; Dechang Chen; Weining Xiong; Lei Xu; Feng Zhou; Jinjun Jiang; Chunxue Bai; Junhua Zheng; Yuanlin Song
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

6.  Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.

Authors:  Peng Zhang; Lihua Zhu; Jingjing Cai; Fang Lei; Juan-Juan Qin; Jing Xie; Ye-Mao Liu; Yan-Ci Zhao; Xuewei Huang; Lijin Lin; Meng Xia; Ming-Ming Chen; Xu Cheng; Xiao Zhang; Deliang Guo; Yuanyuan Peng; Yan-Xiao Ji; Jing Chen; Zhi-Gang She; Yibin Wang; Qingbo Xu; Renfu Tan; Haitao Wang; Jun Lin; Pengcheng Luo; Shouzhi Fu; Hongbin Cai; Ping Ye; Bing Xiao; Weiming Mao; Liming Liu; Youqin Yan; Mingyu Liu; Manhua Chen; Xiao-Jing Zhang; Xinghuan Wang; Rhian M Touyz; Jiahong Xia; Bing-Hong Zhang; Xiaodong Huang; Yufeng Yuan; Rohit Loomba; Peter P Liu; Hongliang Li
Journal:  Circ Res       Date:  2020-04-17       Impact factor: 17.367

7.  Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.

Authors:  Muthiah Vaduganathan; Orly Vardeny; Thomas Michel; John J V McMurray; Marc A Pfeffer; Scott D Solomon
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245

8.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.